C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2002
11/14/2002	US20020168768 Composition for use in the generation and culturing of skin
11/14/2002	US20020168767 Isolating human nervous system tissue from fetal tissue; obtain human fetal cells, culture, immunodeplete, isolate nervous system tissue
11/14/2002	US20020168766 Generating genetically engineered pluripotent stem cells for use in gene therapy; obtain cells transform with preferential expression vector, recover genetically engineered cells
11/14/2002	US20020168765 Early stage multipotential stem cells in colonies of bone marrow stromal cells
11/14/2002	US20020168763 Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
11/14/2002	US20020168754 Nucleotide sequences coding polypeptides for use in the treatment of gastric, testicular, retinal, nervous system and immunological disorders
11/14/2002	US20020168749 Nucleotide sequences coding polypeptide for use in the treatment and prevention of wounds, angiogenesis, restenosis, atherosclerosis, inflammation, nervous system disorders and cancer
11/14/2002	US20020168745 Transacylases of the paclitaxel biosynthetic pathway
11/14/2002	US20020168740 Kinase for use in the treatment of inflammation, viral infection, cancer, sepsis, psoriasis and restenosis
11/14/2002	US20020168736 Nucleotide sequences coding protein for use in the treatment of immunological disorders
11/14/2002	US20020168735 Protein for use in the prevention of fungal infection
11/14/2002	US20020168724 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders
11/14/2002	US20020168723 Nucleotide sequences coding protein for use in the treatment of nervous system disorders
11/14/2002	US20020168719 Nucleotide sequences coding proteins for use in the treatment autoimmune and immunological diseases
11/14/2002	US20020168718 Enzyme-mediated modification of fibrin for tissue engineering
11/14/2002	US20020168716 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of tumors, immunological, autoimmune, skin, viral, bone, nervous system and inflammatory disorders
11/14/2002	US20020168715 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/14/2002	US20020168711 Nucleic acids, proteins, and antibodies
11/14/2002	US20020168710 Anticancer agents; cardiovascular disorders; anticholesterol agents
11/14/2002	US20020168708 Nucleotide sequences coding polypeptide for use in the treatment of parkinson's, chronic obstructive airways, irritable bowel syndrome, muscle and urogenital disorders
11/14/2002	US20020168702 Isolating cells expressing secreted proteins
11/14/2002	US20020168695 Detecting cell proliferative disorder in humans; obtain tissue sample, incubate with probe, detect signal from tissue sample, signal indicates cancer
11/14/2002	US20020168694 Maintaining stem cells of flies; obtain cells, activate signal transduction, propagate and culture cells
11/14/2002	US20020168690 Peptide for use in the treatment of arthritis
11/14/2002	US20020168672 Nucleotide sequences coding proteins for use in the treatment of tumors
11/14/2002	US20020168660 Stem cell self-renewal and lineage commitment
11/14/2002	US20020168646 Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
11/14/2002	US20020168635 Nucleotide sequences coding polypeptides for use in screening modulators of taste
11/14/2002	US20020168628 Variant of LAV viruses
11/14/2002	US20020168623 Compositions and methods for induction of proteins involved in xenobiotic metabolism
11/14/2002	US20020168415 Biocompatible; culture product; anticancer agents
11/14/2002	US20020168385 Adeno-associated virus vector for boosting immunogenicity of cells
11/14/2002	US20020168384 Vaccine for poultry respiratory disorders
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168373 House dust mite allergen, Der f VII, and uses therefor
11/14/2002	US20020168361 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit
11/14/2002	US20020168357 Administering to a mammal an antibody capable of binding native tissue factor, and linked covalently to a cell antigen or an effector molecule to provide complement fixing ability and antibody dependent cell mediated cytotoxicity
11/14/2002	US20020168351 Fusion cells and cytokine compositions for treatment of disease
11/14/2002	US20020168350 Methods for treating disorders of neuronal deficiency with bone marrow-derived cells
11/14/2002	US20020168347 Monocyte derived cells, in a purified form, presenting antigenic epitopes on their membranes after interioriztion and processing of an antigen-antibody complex, such epitope corresponding to proteolytic degradation product of antigen
11/14/2002	US20020168345 Methods of monitoring HIV drug resistance using adenoviral vectors
11/14/2002	DE10146903C1 In vitro preparation of tissue and organs, useful as grafts for repairing defects and for testing compounds, by seeding matrix that is treated to improve cellular adhesion
11/14/2002	DE10120265A1 AAV-Helferplasmide zur Helfervirus-freien Verpackung und Pseudotypisierung von AAV-Vektoren AAV helper plasmids for helper virus-free packaging and Pseudotyping AAV vectors
11/14/2002	CA2452844A1 Dose response-based methods for identifying receptors having alterations in signaling
11/14/2002	CA2452245A1 Recombinant fusion proteins and the trimers thereof
11/14/2002	CA2447360A1 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	CA2446838A1 Novel mutation
11/14/2002	CA2446819A1 Dna molecules encoding macaca mulatta androgen receptor
11/14/2002	CA2446810A1 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	CA2446788A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	CA2446643A1 Materials and methods for producing tomato yellow leaf curl virus resistance in plants
11/14/2002	CA2446458A1 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	CA2446437A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	CA2446062A1 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	CA2445982A1 Sperm-specific cation channel, and uses therefor
11/14/2002	CA2445781A1 Peptidylarginine deiminase 6
11/14/2002	CA2445049A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	CA2438978A1 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	CA2435142A1 Kinases and phosphatases
11/13/2002	EP1256628A2 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/13/2002	EP1256625A1 Immortalized vascular adventitial cell line
11/13/2002	EP1256348A1 Remedies for hepatitis c
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255859A2 Tissue specific genes of diagnostic import
11/13/2002	EP1255857A2 Method of identifying toxic agents using differential gene expression
11/13/2002	EP1255853A2 Methods of protein destabilization and uses thereof
11/13/2002	EP1255850A1 AMPLIFICATION OF $i(CYP24) AND USES THEREOF
11/13/2002	EP1255848A2 Methods for enhancing the production of cytokines in cell cultur e
11/13/2002	EP1255847A2 Alteration of growth and adaptation under hypoxic conditions
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255842A1 Larynx carcinoma-associated protein larcap-1
11/13/2002	EP1255840A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility
11/13/2002	EP1255839A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255834A2 Gtpase activating proteins
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255831A2 Sperm specific proteins
11/13/2002	EP1255830A2 Cbp86, a sperm specific protein
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255824A2 Non-human transgenic animals for the study of neurodegenerative syndromes
11/13/2002	EP1255821A2 Protein c derivatives
11/13/2002	EP1255820A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof
11/13/2002	EP1255819A2 Human kinases
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255813A1 Multipotent neural stem cells from peripheral tissues and uses thereof
11/13/2002	EP1255812A1 Process for the production of non-human embryos of high-genetic value and of predetermined sex
11/13/2002	EP1255780A1 Methods and compositions for generating human monoclonal antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255774A1 Transgenic animal model for obesity expressing foxc2
11/13/2002	EP1255773A2 Insecticidal proteins from bacillus thuringiensis
11/13/2002	EP1255771A1 Novel compounds
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1255437A1 Transgenic animal expressing a multiple mutated form of presenilin 1
11/13/2002	EP0956340A4 In culture proliferation of human pancreatic endocrine cells

1 ... 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 ... 1827